Explore the full directors' dealings record of Apimeds Pharmaceuticals US, Inc., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €21.7m. The latest transaction was reported on 20 May 2025 (Attribution). Among the most active insiders: Kim Christopher. The full history is free.
5
Insider Decl.
0
Thresholds
€2m
3 ops.
Buy Volume
·
0 ops.
Sell Volume
38Σ signal
Buys €2m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.